4. Delta-8 THC products often involve use of potentially harmful chemicals to create the concentrations of delta-8 THC claimed in the marketplace. Thus, historical use of cannabis cannot be relied upon in establishing a level of safety for these products in humans. The FDA is aware of media reports of delta-8 THC products getting consumers “high.” The FDA is also concerned that delta-8 THC products likely expose consumers to much higher levels of the substance than are naturally occurring in hemp cannabis raw extracts.
GAS STATIONS THAT SELL DISPOSABLE VAPES NEAR ME CODE
National poison control centers received 2,362 exposure cases of delta-8 THC products between Janu(i.e., date that delta-8 THC product code was added to database), and February 28, 2022. Adverse events included, but were not limited to: hallucinations, vomiting, tremor, anxiety, dizziness, confusion, and loss of consciousness.66% described adverse events after ingestion of delta-8 THC-containing food products (e.g., brownies, gummies).55% required intervention (e.g., evaluation by emergency medical services) or hospital admission.77% involved adults, 8% involved pediatric patients less than 18 years of age, and 15% did not report age.The FDA received 104 reports of adverse events in patients who consumed delta-8 THC products between December 1, 2020, and February 28, 2022.
The FDA has received adverse event reports involving delta-8 THC-containing products. This deceptive marketing of unproven treatments raises significant public health concerns because patients and other consumers may use them instead of approved therapies to treat serious and even fatal diseases. Selling unapproved products with unsubstantiated therapeutic claims is not only a violation of federal law, but also can put consumers at risk, as these products have not been proven to be safe or effective. Additionally, some of these products may be labeled simply as “hemp products,” which may mislead consumers who associate “hemp” with “non-psychoactive.” Furthermore, the FDA is concerned by the proliferation of products that contain delta-8 THC and are marketed for therapeutic or medical uses, although they have not been approved by the FDA. Some concerns include variability in product formulations and product labeling, other cannabinoid and terpene content, and variable delta-8 THC concentrations. These products have not been evaluated or approved by the FDA for safe use in any context. The FDA is aware of the growing concerns surrounding delta-8 THC products currently being sold online and in stores. Delta-8 THC products have not been evaluated or approved by the FDA for safe use and may be marketed in ways that put the public health at risk. Here are 5 things you should know about delta-8 THC to keep you and those you care for safe from products that may pose serious health risks: 1. They may be marketed in ways that put the public health at risk and should especially be kept out of reach of children and pets. It is important for consumers to be aware that delta-8 THC products have not been evaluated or approved by the FDA for safe use in any context. As a result, concentrated amounts of delta-8 THC are typically manufactured from hemp-derived cannabidiol (CBD). Delta-8 THC is one of over 100 cannabinoids produced naturally by the cannabis plant but is not found in significant amounts in the cannabis plant. Delta-8 tetrahydrocannabinol, also known as delta-8 THC, is a psychoactive substance found in the Cannabis sativa plant, of which marijuana and hemp are two varieties.
0 kommentar(er)
